Publications by authors named "Erin N Howe"

Claim this Profile
T
Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer.
Bhavana Palakurthi, Shaneann R Fross, Ian H Guldner, Emilija Aleksandrovic, Xiyu Liu, Erin N Howe

Nat Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10.
Ian H Guldner, Qingfei Wang, Lin Yang, Samantha M Golomb, Zhuo Zhao, Erin N Howe

Cell· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rab11b-mediated integrin recycling promotes brain metastatic adaptation and outgrowth.
Erin N Howe, Miranda D Burnette, Melanie E Justice, Patricia M Schnepp, Victoria Hedrick

Nat Commun· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Scaffold Evaluation and Systems-Level Transcriptome-Based Analysis for Accelerated Lead Optimization Reveals Ribosomal Targeting Spirooxindole Cyclopropanes.
Kevin X Rodriguez, Erin N Howe, Emily P Bacher, Miranda Burnette, Jennifer L Meloche

ChemMedChem· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer.
Yingjia Ni, Keon R Schmidt, Barnes A Werner, Jenna K Koenig, Ian H Guldner, Erin N Howe

Nat Commun· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GAD1 Upregulation Programs Aggressive Features of Cancer Cell Metabolism in the Brain Metastatic Microenvironment.
Patricia M Schnepp, Dennis D Lee, Ian H Guldner, Treasa K O'Tighearnaigh, Erin N Howe

Cancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-induced Stromal STAT1 Accelerates Breast Cancer via Deregulating Tissue Homeostasis.
Victoria R Zellmer, Patricia M Schnepp, Sarah L Fracci, Xuejuan Tan, Erin N Howe

Mol Cancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b.
Reema S Wahdan-Alaswad, Dawn R Cochrane, Nicole S Spoelstra, Erin N Howe, Susan M Edgerton

Horm Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
Dawn R Cochrane, Sebastián Bernales, Britta M Jacobsen, Diana M Cittelly, Erin N Howe

Breast Cancer Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA regulation of epithelial plasticity in cancer.
Nicholas C D'Amato, Erin N Howe, Jennifer K Richer

Cancer Lett· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer.
Erin N Howe, Dawn R Cochrane, Diana M Cittelly, Jennifer K Richer

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.
Diana M Cittelly, Irina Dimitrova, Erin N Howe, Dawn R Cochrane, Annie Jean

Mol Cancer Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer.
Dawn R Cochrane, Britta M Jacobsen, Keith D Connaghan, Erin N Howe, David L Bain

Mol Cell Endocrinol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity.
Erin N Howe, Dawn R Cochrane, Jennifer K Richer

J Mammary Gland Biol Neoplasia· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers.
Dawn R Cochrane, Erin N Howe, Nicole S Spoelstra, Jennifer K Richer

J Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
Erin N Howe, Dawn R Cochrane, Jennifer K Richer

Breast Cancer Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer.
Dawn R Cochrane, Diana M Cittelly, Erin N Howe, Nicole S Spoelstra, Erin L McKinsey

Horm Cancer· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents.
Dawn R Cochrane, Nicole S Spoelstra, Erin N Howe, Steven K Nordeen, Jennifer K Richer

Mol Cancer Ther· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis